SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-20-000150
Filing Date
2020-09-01
Accepted
2020-08-31 21:38:14
Documents
16
Period of Report
2020-08-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20200826.htm   iXBRL 8-K 45858
2 EX-3.1 a202009018-kex31.htm EX-3.1 13675
3 EX-3.2 a202009018-kex32.htm EX-3.2 182551
  Complete submission text file 0000882104-20-000150.txt   428306

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20200826.xsd EX-101.SCH 2405
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20200826_cal.xml EX-101.CAL 698
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20200826_def.xml EX-101.DEF 1631
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20200826_lab.xml EX-101.LAB 24977
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20200826_pre.xml EX-101.PRE 13175
9 EXTRACTED XBRL INSTANCE DOCUMENT pdli-20200826_htm.xml XML 10954
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 201153162
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences